Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?
Am J Obstet Gynecol
; 179(3 Pt 2): S68-77, 1998 Sep.
Article
em En
| MEDLINE
| ID: mdl-9753313
ABSTRACT
PIP: This article reviews seven recent studies that addressed the association between second- and third-generation oral contraceptive (OC) use and the risk of ischemic stroke and/or myocardial infarction. The one US study found no risk of ischemic stroke or myocardial infarction with low-dose OC use, while the European studies detected increased risks of both these events. The European studies showed no difference between OC generations in terms of the occurrence of ischemic stroke; however, the risk of myocardial infarction was consistently lower for third- compared with second-generation OCs. In all instances, cardiovascular risk factors other than OC use, especially smoking and hypertension, play the predominant role in the occurrence of both ischemic stroke and myocardial infarction.
Palavras-chave
Americas; Biology; Contraception; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Contraceptive Methods--side effects; Desogestrel--pharmacodynamics; Developed Countries; Diseases; Epidemiologic Methods; Europe; Family Planning; Gestodene--pharmacodynamics; Heart Diseases; Ischemia; Levonorgestrel--pharmacodynamics; Literature Review; Myocardial Infarction; North America; Northern America; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Research Methodology; Risk Factors; United States; Vascular Diseases
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Transtornos Cerebrovasculares
/
Anticoncepcionais Orais Hormonais
/
Infarto do Miocárdio
Idioma:
En
Ano de publicação:
1998
Tipo de documento:
Article